Cargando…
Exploring the Validity of Available Markers and Indices in the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) in People with Type 2 Diabetes in Saudi Arabia
Nonalcoholic fatty liver disease (NAFLD) is common among Saudi patients with type 2 diabetes (T2DM). However, recommended clinical procedures to detect it are unavailable in many locations. Therefore, better and more available diagnostic biomarkers for NAFLD are needed. Various serum parameters were...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887592/ https://www.ncbi.nlm.nih.gov/pubmed/36648875 http://dx.doi.org/10.3390/diseases11010010 |
_version_ | 1784880372999258112 |
---|---|
author | Ajabnoor, Ghada M. A. Bahijri, Suhad M. Enani, Sumia Mohammad Alsheikh, Lubna Ahmed, Maimoona Alhozali, Amani Al-Shali, Khalid Eldakhakhny, Basmah Medhat Alamoudi, Aliaa A. Al-Ahmadi, Jawaher Borai, Anwar Al-Mowallad, Alaa Salem Tuomilehto, Jaakko |
author_facet | Ajabnoor, Ghada M. A. Bahijri, Suhad M. Enani, Sumia Mohammad Alsheikh, Lubna Ahmed, Maimoona Alhozali, Amani Al-Shali, Khalid Eldakhakhny, Basmah Medhat Alamoudi, Aliaa A. Al-Ahmadi, Jawaher Borai, Anwar Al-Mowallad, Alaa Salem Tuomilehto, Jaakko |
author_sort | Ajabnoor, Ghada M. A. |
collection | PubMed |
description | Nonalcoholic fatty liver disease (NAFLD) is common among Saudi patients with type 2 diabetes (T2DM). However, recommended clinical procedures to detect it are unavailable in many locations. Therefore, better and more available diagnostic biomarkers for NAFLD are needed. Various serum parameters were suggested, and algorithms that employ routine measurements in clinical practice have been developed for the prediction of fat stores in the liver in different populations. However, no such studies have been conducted on Saudis. We aimed to compare selected biochemical markers and calculated indices in T2DM patients diagnosed with NAFLD and patients without NAFLD to find the best markers associated with NAFLD. A cross-sectional study was employed to recruit 67 people with T2DM from endocrine outpatient clinics at King Abdul-Aziz University Hospital. NAFLD was detected by ultrasonography in 28 patients. Demographic information, anthropometric, and blood pressure (BP) measurements were taken. Fasting blood samples were obtained to measure glucose, glycated haemoglobin, lipid profile, liver function tests, and highly sensitive C-reactive protein. Fatty liver index, hepatic steatosis index, NAFLD-liver fat score, and triglyceride and glucose index were calculated. Following stepwise forward likelihood ratio regression with independent variables included in one model using binary logistic regression with age and waist circumference (WC) entered as covariates, elevated diastolic BP and low high-density lipoprotein- cholesterol remained significantly associated with NAFLD (p = 0.002 and 0.03, respectively). However, none of the investigated indices could be used to diagnose the disease adequately due to low specificity, even after calculating new cut-off values. Investigating novel markers and adjusting existing equations used to calculate indices to improve sensitivity and specificity in our population is needed. |
format | Online Article Text |
id | pubmed-9887592 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98875922023-02-01 Exploring the Validity of Available Markers and Indices in the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) in People with Type 2 Diabetes in Saudi Arabia Ajabnoor, Ghada M. A. Bahijri, Suhad M. Enani, Sumia Mohammad Alsheikh, Lubna Ahmed, Maimoona Alhozali, Amani Al-Shali, Khalid Eldakhakhny, Basmah Medhat Alamoudi, Aliaa A. Al-Ahmadi, Jawaher Borai, Anwar Al-Mowallad, Alaa Salem Tuomilehto, Jaakko Diseases Article Nonalcoholic fatty liver disease (NAFLD) is common among Saudi patients with type 2 diabetes (T2DM). However, recommended clinical procedures to detect it are unavailable in many locations. Therefore, better and more available diagnostic biomarkers for NAFLD are needed. Various serum parameters were suggested, and algorithms that employ routine measurements in clinical practice have been developed for the prediction of fat stores in the liver in different populations. However, no such studies have been conducted on Saudis. We aimed to compare selected biochemical markers and calculated indices in T2DM patients diagnosed with NAFLD and patients without NAFLD to find the best markers associated with NAFLD. A cross-sectional study was employed to recruit 67 people with T2DM from endocrine outpatient clinics at King Abdul-Aziz University Hospital. NAFLD was detected by ultrasonography in 28 patients. Demographic information, anthropometric, and blood pressure (BP) measurements were taken. Fasting blood samples were obtained to measure glucose, glycated haemoglobin, lipid profile, liver function tests, and highly sensitive C-reactive protein. Fatty liver index, hepatic steatosis index, NAFLD-liver fat score, and triglyceride and glucose index were calculated. Following stepwise forward likelihood ratio regression with independent variables included in one model using binary logistic regression with age and waist circumference (WC) entered as covariates, elevated diastolic BP and low high-density lipoprotein- cholesterol remained significantly associated with NAFLD (p = 0.002 and 0.03, respectively). However, none of the investigated indices could be used to diagnose the disease adequately due to low specificity, even after calculating new cut-off values. Investigating novel markers and adjusting existing equations used to calculate indices to improve sensitivity and specificity in our population is needed. MDPI 2023-01-15 /pmc/articles/PMC9887592/ /pubmed/36648875 http://dx.doi.org/10.3390/diseases11010010 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ajabnoor, Ghada M. A. Bahijri, Suhad M. Enani, Sumia Mohammad Alsheikh, Lubna Ahmed, Maimoona Alhozali, Amani Al-Shali, Khalid Eldakhakhny, Basmah Medhat Alamoudi, Aliaa A. Al-Ahmadi, Jawaher Borai, Anwar Al-Mowallad, Alaa Salem Tuomilehto, Jaakko Exploring the Validity of Available Markers and Indices in the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) in People with Type 2 Diabetes in Saudi Arabia |
title | Exploring the Validity of Available Markers and Indices in the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) in People with Type 2 Diabetes in Saudi Arabia |
title_full | Exploring the Validity of Available Markers and Indices in the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) in People with Type 2 Diabetes in Saudi Arabia |
title_fullStr | Exploring the Validity of Available Markers and Indices in the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) in People with Type 2 Diabetes in Saudi Arabia |
title_full_unstemmed | Exploring the Validity of Available Markers and Indices in the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) in People with Type 2 Diabetes in Saudi Arabia |
title_short | Exploring the Validity of Available Markers and Indices in the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) in People with Type 2 Diabetes in Saudi Arabia |
title_sort | exploring the validity of available markers and indices in the diagnosis of nonalcoholic fatty liver disease (nafld) in people with type 2 diabetes in saudi arabia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887592/ https://www.ncbi.nlm.nih.gov/pubmed/36648875 http://dx.doi.org/10.3390/diseases11010010 |
work_keys_str_mv | AT ajabnoorghadama exploringthevalidityofavailablemarkersandindicesinthediagnosisofnonalcoholicfattyliverdiseasenafldinpeoplewithtype2diabetesinsaudiarabia AT bahijrisuhadm exploringthevalidityofavailablemarkersandindicesinthediagnosisofnonalcoholicfattyliverdiseasenafldinpeoplewithtype2diabetesinsaudiarabia AT enanisumiamohammad exploringthevalidityofavailablemarkersandindicesinthediagnosisofnonalcoholicfattyliverdiseasenafldinpeoplewithtype2diabetesinsaudiarabia AT alsheikhlubna exploringthevalidityofavailablemarkersandindicesinthediagnosisofnonalcoholicfattyliverdiseasenafldinpeoplewithtype2diabetesinsaudiarabia AT ahmedmaimoona exploringthevalidityofavailablemarkersandindicesinthediagnosisofnonalcoholicfattyliverdiseasenafldinpeoplewithtype2diabetesinsaudiarabia AT alhozaliamani exploringthevalidityofavailablemarkersandindicesinthediagnosisofnonalcoholicfattyliverdiseasenafldinpeoplewithtype2diabetesinsaudiarabia AT alshalikhalid exploringthevalidityofavailablemarkersandindicesinthediagnosisofnonalcoholicfattyliverdiseasenafldinpeoplewithtype2diabetesinsaudiarabia AT eldakhakhnybasmahmedhat exploringthevalidityofavailablemarkersandindicesinthediagnosisofnonalcoholicfattyliverdiseasenafldinpeoplewithtype2diabetesinsaudiarabia AT alamoudialiaaa exploringthevalidityofavailablemarkersandindicesinthediagnosisofnonalcoholicfattyliverdiseasenafldinpeoplewithtype2diabetesinsaudiarabia AT alahmadijawaher exploringthevalidityofavailablemarkersandindicesinthediagnosisofnonalcoholicfattyliverdiseasenafldinpeoplewithtype2diabetesinsaudiarabia AT boraianwar exploringthevalidityofavailablemarkersandindicesinthediagnosisofnonalcoholicfattyliverdiseasenafldinpeoplewithtype2diabetesinsaudiarabia AT almowalladalaasalem exploringthevalidityofavailablemarkersandindicesinthediagnosisofnonalcoholicfattyliverdiseasenafldinpeoplewithtype2diabetesinsaudiarabia AT tuomilehtojaakko exploringthevalidityofavailablemarkersandindicesinthediagnosisofnonalcoholicfattyliverdiseasenafldinpeoplewithtype2diabetesinsaudiarabia |